精神分裂症中氧化应激相关通路与诊断和预测价值的研究进展

doi:10.3969/j.issn.1006-5725.2024.20.019

Abstract

Abstract:

Schizophrenia is a severe mental illness with a significant disease burden. The interaction between oxidative stress and pro-inflammatory factors promotes chronic neuroinflammation and immune damage， leads to dysregulation of dopaminergic and glutamatergic pathways and occurrence of psychotic symptoms and is believed to be closely related to the pathogenesis of schizophrenia. In this paper， we aim to identify biomarkers within the tryptophan kynurenine metabolic pathway， the WNT/β-Catenin pathway and the NF-κB pathway， and dopamine metabolism. These pathways have been extensively studied and are known to be involved in the interaction between inflammation and oxidative stress. We will also explore the potential application of related antioxidants in the diagnosis and treatment of schizophrenia， summarizing their current research progress.

Key words: oxidative stress, inflammatory factor, schizophrenia, biomarker

CLC Number:

R749.3

Tianyue YU,Qian GUO,Hao HU,Yujing SU,Jianhua CHEN. Advances in oxidative stress⁃related pathways with diagnostic and predictive value in schizophrenia[J]. The Journal of Practical Medicine, 2024, 40(20): 2935-2940.

References 50

1	JAUHAR S， JOHNSTONE M， MCKENNA P J. Schizophrenia ［J］. Lancet， 2022， 399（10323）： 473-486. doi:10.1016/s0140-6736(21)01730-x doi: 10.1016/s0140-6736(21)01730-x
2	TALUKDAR P M， ABDUL F， MAES M， et al. Maternal Immune Activation Causes Schizophrenia-like Behaviors in the Offspring through Activation of Immune-Inflammatory， Oxidative and Apoptotic Pathways， and Lowered Antioxidant Defenses and Neuroprotection ［J］. Mol Neurobiol， 2020， 57（10）： 4345-4361. doi:10.1007/s12035-020-02028-8 doi: 10.1007/s12035-020-02028-8
3	KUMAR V， BISHAYEE K， PARK S， et al. Oxidative stress in cerebrovascular disease and associated diseases ［J］. Front Endocrinol （Lausanne）， 2023， 14： 1124419. doi:10.3389/fendo.2023.1124419 doi: 10.3389/fendo.2023.1124419
4	ROBERTS R C. Mitochondrial dysfunction in schizophrenia： With a focus on postmortem studies ［J］. Mitochondrion， 2021， 56： 91-101. doi:10.1016/j.mito.2020.11.009 doi: 10.1016/j.mito.2020.11.009
5	PALANIYAPPAN L， PARK M T M， JEON P， et al. Is There a Glutathione Centered Redox Dysregulation Subtype of Schizophrenia？［J］. Antioxidants （Basel）， 2021， 10（11）：1703. doi:10.3390/antiox10111703 doi: 10.3390/antiox10111703
6	RAMBAUD V， MARZO A， CHAUMETTE B. Oxidative Stress and Emergence of Psychosis ［J］. Antioxidants （Basel）， 2022， 11（10）：1870. doi:10.3390/antiox11101870 doi: 10.3390/antiox11101870
7	CAO B， CHEN Y， REN Z， et al. Dysregulation of kynurenine pathway and potential dynamic changes of kynurenine in schizophrenia： A systematic review and meta-analysis ［J］. Neurosci Biobehav Rev， 2021， 123： 203-214. doi:10.1016/j.neubiorev.2021.01.018 doi: 10.1016/j.neubiorev.2021.01.018
8	BEHL T， KAUR I， SEHGAL A， et al. The Footprint of Kynurenine Pathway in Neurodegeneration： Janus-Faced Role in Parkinson's Disorder and Therapeutic Implications ［J］. Int J Mol Sci， 2021， 22（13）：6737. doi:10.3390/ijms22136737 doi: 10.3390/ijms22136737
9	ASLAMKHAN A G， XU Q， LOUGHLIN A， et al. Characterization of indoleamine-2，3-dioxygenase 1， tryptophan-2，3-dioxygenase， and Ido1/Tdo2 knockout mice ［J］. Toxicol Appl Pharmacol， 2020， 406： 115216. doi:10.1016/j.taap.2020.115216 doi: 10.1016/j.taap.2020.115216
10	SAVONIJE K， MEEK A， WEAVER D F. Indoleamine 2，3-Dioxygenase as a Therapeutic Target for Alzheimer's Disease and Geriatric Depression ［J］. Brain Sci， 2023， 13（6）：852. doi:10.3390/brainsci13060852 doi: 10.3390/brainsci13060852
11	KINDLER J， LIM C K， WEICKERT C S， et al. Dysregulation of kynurenine metabolism is related to proinflammatory cytokines， attention， and prefrontal cortex volume in schizophrenia ［J］. Mol Psychiatry， 2020， 25（11）： 2860-2872. doi:10.1038/s41380-019-0401-9 doi: 10.1038/s41380-019-0401-9
12	WURFEL B E， DREVETS W C， BLISS S A， et al. Serum kynurenic acid is reduced in affective psychosis ［J］. Transl Psychiatry， 2017， 7（5）： e1115. doi:10.1038/tp.2017.88 doi: 10.1038/tp.2017.88
13	JOAQUIM H P G， COSTA A C， GATTAZ W F， et al. Kynurenine is correlated with IL-1β in plasma of schizophrenia patients ［J］. J Neural Transm （Vienna）， 2018， 125（5）： 869-873. doi:10.1007/s00702-018-1838-8 doi: 10.1007/s00702-018-1838-8
14	DE PICKER L， FRANSEN E， COPPENS V， et al. Immune and Neuroendocrine Trait and State Markers in Psychotic Illness： Decreased Kynurenines Marking Psychotic Exacerbations ［J］. Front Immunol， 2020， 10： 2971. doi:10.3389/fimmu.2019.02971 doi: 10.3389/fimmu.2019.02971
15	CHIAPPELLI J， POCIVAVSEK A， NUGENT K L， et al. Stress-induced increase in kynurenic acid as a potential biomarker for patients with schizophrenia and distress intolerance ［J］. JAMA Psychiatry， 2014， 71（7）： 761-768. doi:10.1001/jamapsychiatry.2014.243 doi: 10.1001/jamapsychiatry.2014.243
16	AFIA A B， VILA È， MACDOWELL K S， et al. Kynurenine pathway in post-mortem prefrontal cortex and cerebellum in schizophrenia： relationship with monoamines and symptomatology ［J］. J Neuroinflammation， 2021， 18（1）： 198. doi:10.1186/s12974-021-02260-6 doi: 10.1186/s12974-021-02260-6
17	MARX W， MCGUINNESS A J， ROCKS T， et al. The kynurenine pathway in major depressive disorder， bipolar disorder， and schizophrenia： a meta-analysis of 101 studies ［J］. Mol Psychiatry， 2021， 26（8）： 4158-4178. doi:10.1038/s41380-020-00951-9 doi: 10.1038/s41380-020-00951-9
18	SKOROBOGATOV K， AUTIER V， FOISELLE M， et al. Kynurenine pathway abnormalities are state-specific but not diagnosis-specific in schizophrenia and bipolar disorder ［J］. Brain Behav Immun Health， 2023， 27： 100584. doi:10.1016/j.bbih.2022.100584 doi: 10.1016/j.bbih.2022.100584
19	STONE T W. Does kynurenic acid act on nicotinic receptors？ An assessment of the evidence ［J］. J Neurochem， 2020， 152（6）： 627-649. doi:10.1111/jnc.14907 doi: 10.1111/jnc.14907
20	VERDONK F， PETIT A C， ABDEL-AHAD P， et al. Microglial production of quinolinic acid as a target and a biomarker of the antidepressant effect of ketamine ［J］. Brain Behav Immun， 2019， 81： 361-373. doi:10.1016/j.bbi.2019.06.033 doi: 10.1016/j.bbi.2019.06.033
21	胡琳，杨艳娟，李洁滢，等. 红景天苷通过激活PI3K/Akt和抑制NF-κB信号通路改善川崎病冠状动脉损伤［J］. 实用医学杂志， 2022， 38（21）： 2657-2662，2669.
22	MARCHETTI B， TIROLO C， L'EPISCOPO F， et al. Parkinson's disease， aging and adult neurogenesis： Wnt/β-catenin signalling as the key to unlock the mystery of endogenous brain repair ［J］. Aging Cell， 2020， 19（3）： e13101. doi:10.1111/acel.13101 doi: 10.1111/acel.13101
23	LIU J， XIAO Q， XIAO J， et al. Wnt/β-catenin signalling： function， biological mechanisms， and therapeutic opportunities ［J］. Signal Transduct Target Ther， 2022， 7（1）： 3. doi:10.1038/s41392-021-00762-6 doi: 10.1038/s41392-021-00762-6
24	ALSABBAN A H， MORIKAWA M， TANAKA Y， et al. Kinesin Kif3b mutation reduces NMDAR subunit NR2A trafficking and causes schizophrenia-like phenotypes in mice ［J］. Embo J， 2020， 39（1）： e101090. doi:10.15252/embj.2018101090 doi: 10.15252/embj.2018101090
25	ZHANG L， LUDDEN C M， CULLEN A J， et al. Nuclear factor kappa B expression in non-small cell lung cancer ［J］. Biomed Pharmacother， 2023， 167： 115459. doi:10.1016/j.biopha.2023.115459 doi: 10.1016/j.biopha.2023.115459
26	VOLK D W， MOROCO A E， ROMAN K M， et al. The Role of the Nuclear Factor-κB Transcriptional Complex in Cortical Immune Activation in Schizophrenia ［J］. Biol Psychiatry， 2019， 85（1）： 25-34. doi:10.1016/j.biopsych.2018.06.015 doi: 10.1016/j.biopsych.2018.06.015
27	NORTH H F， BRUGGEMANN J， CROPLEY V， et al. Increased peripheral inflammation in schizophrenia is associated with worse cognitive performance and related cortical thickness reductions ［J］. Eur Arch Psychiatry Clin Neurosci， 2021， 271（4）： 595-607. doi:10.1007/s00406-021-01237-z doi: 10.1007/s00406-021-01237-z
28	FRAGUAS D， DÍAZ-CANEJA C M， AYORA M， et al. Oxidative Stress and Inflammation in First-Episode Psychosis： A Systematic Review and Meta-analysis ［J］. Schizophrenia Bulletin， 2019， 45（4）： 742-751. doi:10.1093/schbul/sby125 doi: 10.1093/schbul/sby125
29	YAN F， MENG X， CHENG X， et al. Potential role between inflammatory cytokines and Tie-2 receptor levels and clinical symptoms in patients with first-episode schizophrenia ［J］. BMC Psychiatry， 2023， 23（1）： 538. doi:10.1186/s12888-023-04913-7 doi: 10.1186/s12888-023-04913-7
30	GOLDSMITH D R， HAROON E， MILLER A H， et al. Association of baseline inflammatory markers and the development of negative symptoms in individuals at clinical high risk for psychosis ［J］. Brain Behav Immun， 2019， 76： 268-274. doi:10.1016/j.bbi.2018.11.315 doi: 10.1016/j.bbi.2018.11.315
31	KHANDAKER G M， STOCHL J， ZAMMIT S， et al. Association between circulating levels of C-reactive protein and positive and negative symptoms of psychosis in adolescents in a general population birth cohort ［J］. J Psychiatr Res， 2021， 143： 534-542. doi:10.1016/j.jpsychires.2020.11.028 doi: 10.1016/j.jpsychires.2020.11.028
32	NISHIMON S， OHNUMA T， TAKEBAYASHI Y， et al. High serum soluble tumor necrosis factor receptor 1 predicts poor treatment response in acute-stage schizophrenia ［J］. Prog Neuropsychopharmacol Biol Psychiatry， 2017， 76： 145-154. doi:10.1016/j.pnpbp.2017.03.006 doi: 10.1016/j.pnpbp.2017.03.006
33	NOTO C， MAES M， OTA V K， et al. High predictive value of immune-inflammatory biomarkers for schizophrenia diagnosis and association with treatment resistance ［J］. World J Biol Psychiatry， 2015， 16（6）： 422-429. doi:10.3109/15622975.2015.1062552 doi: 10.3109/15622975.2015.1062552
34	FOND G， FAUGERE M， RICHIERI R， et al. Depressive symptoms and chronic peripheral inflammation are associated with impaired functional remission in schizophrenia independently of psychotic remission ［J］. J Affect Disord， 2021， 280（Pt A）： 267-271. doi:10.1016/j.jad.2020.11.046 doi: 10.1016/j.jad.2020.11.046
35	WIUM-ANDERSEN M K， ØRSTED D D， NORDESTGAARD B G. Elevated C-reactive protein associated with late- and very-late-onset schizophrenia in the general population： A prospective study ［J］. Schizophr Bull， 2014， 40（5）： 1117-1127. doi:10.1093/schbul/sbt120 doi: 10.1093/schbul/sbt120
36	BüELER H. Mitochondrial and Autophagic Regulation of Adult Neurogenesis in the Healthy and Diseased Brain ［J］. Int J Mol Sci， 2021， 22（7）：3342. doi:10.3390/ijms22073342 doi: 10.3390/ijms22073342
37	CHAGRAOUI A， ANOUAR Y， DE DEURWAERDERE P， et al. To what extent may aminochrome increase the vulnerability of dopaminergic neurons in the context of Parkinson's disease ［J］. Int J Biochem Cell Biol， 2024， 168： 106528. doi:10.1016/j.biocel.2024.106528 doi: 10.1016/j.biocel.2024.106528
38	ZHANG S， WANG R， WANG G. Impact of Dopamine Oxidation on Dopaminergic Neurodegeneration ［J］. ACS Chem Neurosci， 2019， 10（2）： 945-953. doi:10.1021/acschemneuro.8b00454 doi: 10.1021/acschemneuro.8b00454
39	VIDAL P M， PACHECO R. Targeting the Dopaminergic System in Autoimmunity ［J］. J Neuroimmune Pharmacol， 2020， 15（1）： 57-73. doi:10.1007/s11481-019-09834-5 doi: 10.1007/s11481-019-09834-5
40	GOH X X， TANG P Y， TEE S F. Effects of antipsychotics on antioxidant defence system in patients with schizophrenia： A meta-analysis ［J］. Psychiatry Res， 2022， 309： 114429. doi:10.1016/j.psychres.2022.114429 doi: 10.1016/j.psychres.2022.114429
41	LAVOIE S， BERGER M， SCHLöGELHOFER M， et al. Erythrocyte glutathione levels as long-term predictor of transition to psychosis ［J］. Transl Psychiatry， 2017， 7（3）： e1064. doi:10.1038/tp.2017.30 doi: 10.1038/tp.2017.30
42	LU Z， WEN T， WANG Y， et al. Peripheral non-enzymatic antioxidants in patients with schizophrenia： A case-control study ［J］. BMC Psychiatry， 2020， 20（1）： 241. doi:10.1186/s12888-020-02635-8 doi: 10.1186/s12888-020-02635-8
43	ZHANG G， LI S， WANG S， et al. The association between serum albumin and depressive symptoms： A cross-sectional study of NHANES data during 2005-2018 ［J］. BMC Psychiatry， 2023， 23（1）： 448. doi:10.1186/s12888-023-04935-1 doi: 10.1186/s12888-023-04935-1
44	MYKEN A N， EBDRUP B H， SØRENSEN M E， et al. Lower Vitamin C Levels Are Associated With Less Improvement in Negative Symptoms in Initially Antipsychotic-Naïve Patients With First-Episode Psychosis ［J］. Int J Neuropsychopharmacol， 2022， 25（8）： 613-618. doi:10.1093/ijnp/pyac029 doi: 10.1093/ijnp/pyac029
45	REZAEI ZONOOZ S， HASANI M， MORVARIDZADEH M， et al. Effect of alpha-lipoic acid on oxidative stress parameters： A systematic review and meta-analysis ［J］. J Funct Foods， 2021， 87： 104774. doi:10.1016/j.jff.2021.104774 doi: 10.1016/j.jff.2021.104774
46	DE LIMA D N J， COSTA FILHO C W L， FROTA I J， et al. α-Lipoic Acid as Adjunctive Treatment for Schizophrenia： A Randomized Double-Blind Study ［J］. J Clin Psychopharmacol， 2023， 43（1）： 39-45. doi:10.1097/jcp.0000000000001639 doi: 10.1097/jcp.0000000000001639
47	SEDLAK T W， NUCIFORA L G， KOGA M， et al. Sulforaphane Augments Glutathione and Influences Brain Metabolites in Human Subjects： A Clinical Pilot Study ［J］. Mol Neuropsychiatry， 2018， 3（4）： 214-22. doi:10.1159/000487639 doi: 10.1159/000487639
48	EDEMANN-CALLESEN H， BERNHARDT N， HLUSICKA E B， et al. Supplement Treatment with NAC and Omega-3 Polyunsaturated Fatty Acids during Pregnancy Partially Prevents Schizophrenia-Related Outcomes in the Poly I：C Rat Model ［J］. Antioxidants （Basel）， 2023， 12（5）：1068. doi:10.3390/antiox12051068 doi: 10.3390/antiox12051068
49	GOH K K， CHEN C Y， CHEN C H， et al. Effects of omega-3 polyunsaturated fatty acids supplements on psychopathology and metabolic parameters in schizophrenia： A meta-analysis of randomized controlled trials ［J］. J Psychopharmacol， 2021， 35（3）： 221-235. doi:10.1177/0269881120981392 doi: 10.1177/0269881120981392
50	刘雪情，宫秀群，王侠，等. 依达拉奉右莰醇治疗血管性痴呆的作用机制研究［J］. 实用医学杂志， 2023， 39（4）： 505-509.

[1]	Yuying HU,Jinming ZHU,Jie LIU,Yawen PAN,Qian ZHANG,Jinqiu FENG. Expression and significance of miR⁃223⁃3p in serum of pregnant women with preterm premature rupture of membranes [J]. The Journal of Practical Medicine, 2024, 40(9): 1275-1279.
[2]	Chen YUAN,Xia ZHAO,Jiabao WU,Hua. YAN. Current research status and application prospects of S1P in asthma [J]. The Journal of Practical Medicine, 2024, 40(7): 936-940.
[3]	Ling XIAO,Chunlei GAO,Wei GUO,Ning WANG,Xuan ZHANG,Ming. LIU. Codonopsis polysaccharide protected LPS⁃induced acute lung injury by inhibiting MAPK/NF⁃κB signaling pathway in mice [J]. The Journal of Practical Medicine, 2024, 40(7): 948-954.
[4]	Kanglin CAI,Jinkai ZHANG,Liangdi RAN,Dajun HU,Zhitao FENG,Huilian. HUANG. Research progress on antidepressant pharmacological effects and mechanisms of Bupleuri Radix⁃Paeoniae Radix Alba herb⁃pair [J]. The Journal of Practical Medicine, 2024, 40(4): 447-452.
[5]	Lihong DING,Shijia GENG,Yujie WANG. Effects of wedelobata on apoptosis and secretion of inflammatory cytokines in the alveolar epithelium infected by Streptococcus pneumonia [J]. The Journal of Practical Medicine, 2024, 40(3): 316-320.
[6]	Jieqiong LIU,Yali YAO,Qian SUI,Ke LI,Fang HUANG,Yongqing. CAO. Based on the novel anti-heart failure drug ARNI， the mechanism of prevention of cardiotoxicity caused by anthracycline antitumor drugs was discussed [J]. The Journal of Practical Medicine, 2024, 40(2): 188-194.
[7]	Bin ZHANG,Wei HU,Rongzhen TAN,Panpan YANG,Jun HU,Zhong YUAN,Gongtao. JIANG. Effects of Yishen Huayu Xugu prescription combined with Dixumab on IL-6， β-CTX and bone mineral density in elderly patients operated for osteoporotic lumbar vertebral compression fractures [J]. The Journal of Practical Medicine, 2024, 40(19): 2766-2771.
[8]	Kaming YANG,Zhenlin LI,Wanwen LAO,Aixia ZHAI,Changlong. BI. Serological biomarkers for diagnosis of diabetes foot： A review of literature [J]. The Journal of Practical Medicine, 2024, 40(16): 2224-2228.
[9]	Ganggang LU,Shenglong LI,Yongqiang ZHAO,Yunpeng JIA,Yonglin LIANG,Yuanbo. ZHAO. Research progress on the correlation between oxidative stress and ferroptosis in diabetic impotence [J]. The Journal of Practical Medicine, 2024, 40(16): 2229-2235.
[10]	Yunlong SUN,Zhe MENG,Xijia WANG,Lu. GAO. Liraglutide ameliorates high glucose⁃induced endothelial cell injuryvia Nrf2 [J]. The Journal of Practical Medicine, 2024, 40(15): 2051-2055.
[11]	Weifeng ZHANG,Hailong MA,Jinling. ZHANG. Effect of PCSK9 inhibitors on inflammation levels and ventricular remodeling after PCI in ST⁃elevation acute myocardial infarction [J]. The Journal of Practical Medicine, 2024, 40(15): 2142-2147.
[12]	Jie YANG,Chunhong LI,Jingfei HUANG,Zhiwei CHEN,Lin. LIU. The expression and clinical significance of hsa_circ_0003922 in endometrioid carcinoma [J]. The Journal of Practical Medicine, 2024, 40(14): 1975-1980.
[13]	Chun LONG,Hongying BI,Changzhen YANG,Jiakai WANG,Yan TANG,Xu. LIU. Emodin upregulates the Sirt2 to attenuate LPS-induced oxidative stress response in RAW264.7 cells [J]. The Journal of Practical Medicine, 2024, 40(13): 1785-1790.
[14]	Xuan QIU,Yishajiang SHAREZATI,Yulan CHEN,Mengmeng WANG,Yu LI,Tulahong GULINAZI,Abuhan ZUBAIDAN,Abulizi ALIYA,Xingchen WANG. Effect of transient receptor potential channel 5 on myocardial pyroptosis in intermittent hypoxia [J]. The Journal of Practical Medicine, 2024, 40(12): 1637-1642.
[15]	Shuhong RUI,Chenfang WANG,Yunhe LI,Junlan PAN,Jianlou WANG. Effects of indobuprofen combined with nicodil on inflammatory factors， myocardial injury markers and platelet function in patients with ACS after PCI [J]. The Journal of Practical Medicine, 2024, 40(12): 1706-1711.

Advances in oxidative stress⁃related pathways with diagnostic and predictive value in schizophrenia

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References 50

Related Articles 15

Recommended Articles

Metrics

Comments